Proto Labs, Inc.
Bear Case (25th pct.)
-81.1% vs price
Base Case (Median)
-73.4% vs price
Bull Case (75th pct.)
-69.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $9.13 | -90.0% | High (40%) |
| PE Comparable | $24.18 | -73.4% | Medium (25%) |
| Growth Trajectory DCF | $22.89 | -74.8% | Medium (20%) |
| Graham Number | $28.15 | -69.0% | High (80%) |
| EV/EBITDA | $27.12 | -70.2% | Medium (20%) |
| EV/FCF | $51.82 | -43.0% | Medium (20%) |
| Earnings Power Value | $11.39 | -87.5% | High (70%) |
Based on 7 out of 8 methods, PRLB appears overvalued at the current price of $90.86. The base case fair value of $24.18 implies 73.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.